About Us
Mission
Axela is delivering on its mission to provide researchers with simple and effective approaches to rapidly understand protein interactions and develop quantitative assays on a single platform.
Strategy
Axela’s strategy is to provide effective research tools to unlock the potential of years of biomarker discovery. By offering a novel technology platform to both the research and future diagnostic markets Axela provides a unique opportunity to rapidly enable, advance and capture the value of novel discoveries.
Growing numbers of dotLab System users are enjoying the benefits of being able to use a single platform to directly understand protein interactions and develop superior quantitative assays. Researchers are adopting dotLab technology because it delivers:
- Real-time measurement of biomolecular complexes: Enabling research into disease management, previously impractical with conventional immunoassay methods
- Improved information content from a single sample: Speeding the transition from protein discovery to application
- Multiple analytical parameters from a single experiment: Enhancing the iterative scientific process
- Simple automated operation: Permitting full technical utilization with minimal training
- Affordable capital and operating costs: Save time and gain labor efficiencies